These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 33148691)

  • 1. Microscopic hematuria is a risk factor for end-stage kidney disease in patients with biopsy-proven diabetic nephropathy.
    Okada S; Samejima KI; Matsui M; Morimoto K; Furuyama R; Tanabe K; Eriguchi M; Akai Y; Saito Y; Tsuruya K
    BMJ Open Diabetes Res Care; 2020 Nov; 8(2):. PubMed ID: 33148691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of non-diabetic kidney diseases in type 2 diabetic patients: Twenty years of single center experience.
    Sakaci T; Ahbap E; Basturk T; Ortaboz M; Ozagari AA; Mazı EE; Eken KG; Hasbal NB; Unsal A
    Clin Nephrol; 2024 May; 101(5):207-221. PubMed ID: 38431824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease.
    Yamanouchi M; Mori M; Hoshino J; Kinowaki K; Fujii T; Ohashi K; Furuichi K; Wada T; Ubara Y
    BMJ Open Diabetes Res Care; 2019; 7(1):e000726. PubMed ID: 31798893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal histology in diabetic nephropathy predicts progression to end-stage kidney disease but not the rate of renal function decline.
    Misra PS; Szeto SG; Krizova A; Gilbert RE; Yuen DA
    BMC Nephrol; 2020 Jul; 21(1):285. PubMed ID: 32682403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex Differences in Biopsy-Confirmed Diabetic Kidney Disease.
    Wang Y; Zhang J; Zhang J; Wu Y; Zhang R; Ren H; Cooper ME; Liu F
    Front Endocrinol (Lausanne); 2021; 12():670674. PubMed ID: 34393995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
    Wu Y; Zhang J; Wang Y; Wang T; Han Q; Guo R; Zhang R; Ren H; Zhu Y; Xu H; Li L; Tong N; Liu F
    J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-year longitudinal trajectory patterns of albuminuria and subsequent rates of end-stage kidney disease and all-cause death: a nationwide cohort study of biopsy-proven diabetic kidney disease.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Shimizu M; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T;
    BMJ Open Diabetes Res Care; 2021 Aug; 9(1):. PubMed ID: 34385147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic features and prognostic factors in older patients with biopsy-proven diabetic nephropathy.
    Zhao L; Ren H; Zhang R; Wang T; Zou Y; Xu H; Li L; Cooper ME; Liu F
    Int Urol Nephrol; 2021 Jun; 53(6):1161-1170. PubMed ID: 33389518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological Spectrum of Clinical Kidney Disease in Type 2 Diabetes Mellitus Patients with special Reference to nonalbuminuric Diabetic Nephropathy: A Kidney Biopsy-based Study.
    Prakash J; Patel PS; Iqbal M; Sharma SS; Singh S; Agrawal NK; Singh U
    J Assoc Physicians India; 2022 Aug; 70(8):11-12. PubMed ID: 36082725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic retinopathy may predict the renal outcomes of patients with diabetic nephropathy.
    Zhang J; Wang Y; Li L; Zhang R; Guo R; Li H; Han Q; Teng G; Liu F
    Ren Fail; 2018 Nov; 40(1):243-251. PubMed ID: 29633887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and outcomes of biopsy-proven diabetic nephropathy.
    Zhuo L; Zhang N; Zou G; Chen D; Li W
    Front Med; 2017 Sep; 11(3):386-392. PubMed ID: 28871455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy, hematuria, and diabetic nephropathy.
    Izzedine H; Fongoro S; Pajot O; Beaufils H; Deray G
    Nephron; 2001 Aug; 88(4):382-3. PubMed ID: 11474236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological predictors for renal prognosis in diabetic nephropathy in diabetes mellitus type 2 patients with overt proteinuria.
    Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
    Nephrology (Carlton); 2012 Jan; 17(1):68-75. PubMed ID: 21933307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remnant cholesterol and the risk of diabetic nephropathy progression to end-stage kidney disease in patients with type 2 diabetes mellitus: a longitudinal cohort study.
    Zhao Y; Liu K; Zou Y; Wu Y; Yang J; Xiao X; Ju X; Yang Q; Lang Y; Liu F
    Endocrine; 2024 Jul; ():. PubMed ID: 39126619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score-Matched Analysis of a Nationwide, Biopsy-Based Cohort Study.
    Yamanouchi M; Furuichi K; Hoshino J; Toyama T; Hara A; Shimizu M; Kinowaki K; Fujii T; Ohashi K; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Hisano S; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Mise K; Makino H; Matsuo S; Ubara Y; Wada T;
    Diabetes Care; 2019 May; 42(5):891-902. PubMed ID: 30833372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes of Japanese type 2 diabetic patients with biopsy-proven diabetic nephropathy.
    Shimizu M; Furuichi K; Toyama T; Kitajima S; Hara A; Kitagawa K; Iwata Y; Sakai N; Takamura T; Yoshimura M; Yokoyama H; Kaneko S; Wada T;
    Diabetes Care; 2013 Nov; 36(11):3655-62. PubMed ID: 24089538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incident heart failure and the subsequent risk of progression to end stage kidney disease in individuals with type 2 diabetes.
    Liu S; Liu JJ; Ang K; Lee J; Chan C; Gurung RL; Zheng H; Tang J; Lim SC
    Cardiovasc Diabetol; 2024 Jun; 23(1):204. PubMed ID: 38879473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.